Literature DB >> 17969460

Eating disorder and metabolism in narcoleptic patients.

Dorothée Chabas1, Christine Foulon, Jesus Gonzalez, Mireille Nasr, Olivier Lyon-Caen, Jean-Claude Willer, Jean-Philippe Derenne, Isabelle Arnulf.   

Abstract

STUDY
OBJECTIVE: To evaluate eating behavior and energy balance as a cause of increased body mass index (BMI) in narcolepsy.
DESIGN: Case controlled pilot study. SETTINGS: University hospital. PARTICIPANTS: 13 patients with narcolepsy (7 "typical" patients, with HLA DQB1*0602 and clear cut cataplexy, with suspected hypocretin deficiency; and 6 "atypical" narcoleptics, i.e., HLA negative or without cataplexy), and 9 healthy controls matched for age, gender, and ethnicity. INTERVENTION: Energy balance was evaluated by measuring BMI, rest energy expenditure with calorimetry, daily food and water intake, and plasma hormone levels. Eating behavior was evaluated using psychometric tests (EAT-40, EDI2, CIDI-2, MADRS).
RESULTS: Patients with narcolepsy (whether typical or not) tended to be overweight and to have a lower basal metabolism than controls. Only patients with typical narcolepsy tended to eat less than controls. Narcoleptic patients who were overweight ate half as much as others, indicating caloric restriction. Plasma glucose, cortisol, thyroid, and sex hormones levels did not differ between groups, while prolactin levels were twice as high in patients with narcolepsy as in controls. Narcoleptic patients had higher EAT-40 scores and more frequent features of bulimia nervosa (independent of depressive mood) than controls, suggesting a mild eating disorder, classified as "Eating Disorder Not Other Specified." DISCUSSION: Both lower basal metabolism and subtle changes in eating behavior (rather than in calorie intake) could explain the positive energy balance leading to overweight in narcolepsy. Eating behavior changes may be a strategy to control weight or to avoid daytime sleepiness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17969460      PMCID: PMC2266283          DOI: 10.1093/sleep/30.10.1267

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  37 in total

1.  Female athletes and eating problems: a meta-analysis.

Authors:  L Smolak; S K Murnen; A E Ruble
Journal:  Int J Eat Disord       Date:  2000-05       Impact factor: 4.861

2.  Increased body-mass index in patients with narcolepsy.

Authors:  A Schuld; J Hebebrand; F Geller; T Pollmächer
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

3.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

5.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

6.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Authors:  Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Journal:  Arch Neurol       Date:  2002-10

Review 7.  Pharmacotherapy for obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; John J McNeil
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.

Authors:  Karine Spiegel; Esra Tasali; Plamen Penev; Eve Van Cauter
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

9.  CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?

Authors:  Isabelle Arnulf; Ling Lin; Jing Zhang; I Jon Russell; Beth Ripley; Mali Einen; Sonia Nevsimalova; Claudio Bassetti; Patrice Bourgin; Seiji Nishino; Emmanuel Mignot
Journal:  Sleep       Date:  2006-08       Impact factor: 5.849

10.  Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.

Authors:  Shahrad Taheri; Ling Lin; Diane Austin; Terry Young; Emmanuel Mignot
Journal:  PLoS Med       Date:  2004-12-07       Impact factor: 11.069

View more
  31 in total

Review 1.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Narcolepsy in African Americans.

Authors:  Makoto Kawai; Ruth O'Hara; Mali Einen; Ling Lin; Emmanuel Mignot
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 3.  The diagnosis and treatment of pediatric narcolepsy.

Authors:  Sona Nevsimalova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

4.  Reward-seeking behavior in human narcolepsy.

Authors:  Alexandra Dimitrova; Rolf Fronczek; Janneke Van der Ploeg; Thomas Scammell; Shiva Gautam; Alvaro Pascual-Leone; Gert Jan Lammers
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

5.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

6.  Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features.

Authors:  Virginia Ponziani; Monia Gennari; Fabio Pizza; Antonio Balsamo; Filippo Bernardi; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 7.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

8.  Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1.

Authors:  Ruth Janke van Holst; Lisa van der Cruijsen; Petra van Mierlo; Gert Jan Lammers; Roshan Cools; Sebastiaan Overeem; Esther Aarts
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

9.  Body mass index-independent metabolic alterations in narcolepsy with cataplexy.

Authors:  Francesca Poli; Giuseppe Plazzi; Guido Di Dalmazi; Danilo Ribichini; Valentina Vicennati; Fabio Pizza; Emmanuel Mignot; Pasquale Montagna; Renato Pasquali; Uberto Pagotto
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

Review 10.  Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.

Authors:  Neil T Feldman
Journal:  Sleep Breath       Date:  2009-07-23       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.